PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UCB SA ADR (UCBJY)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US9034801012

Sector

Healthcare

Highlights

Market Cap

$30.71B

EPS (TTM)

$3.11

PE Ratio

24.84

PEG Ratio

2.29

Total Revenue (TTM)

$2.79B

Gross Profit (TTM)

$1.94B

EBITDA (TTM)

$644.00M

Year Range

$63.58 - $106.60

Target Price

$130.95

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
UCBJY vs. SPOT
Popular comparisons:
UCBJY vs. SPOT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in UCB SA ADR, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


220.00%240.00%260.00%280.00%300.00%320.00%340.00%360.00%NovemberDecember2025FebruaryMarchApril
236.14%
273.02%
UCBJY (UCB SA ADR)
Benchmark (^GSPC)

Returns By Period

UCB SA ADR had a return of -21.72% year-to-date (YTD) and 23.50% in the last 12 months. Over the past 10 years, UCB SA ADR had an annualized return of 10.15%, while the S&P 500 benchmark had an annualized return of 9.68%, indicating that UCB SA ADR performed slightly bigger than the benchmark.


UCBJY

YTD

-21.72%

1M

-21.74%

6M

-18.69%

1Y

23.50%

5Y*

12.71%

10Y*

10.15%

^GSPC (Benchmark)

YTD

-10.18%

1M

-5.91%

6M

-9.57%

1Y

5.19%

5Y*

12.98%

10Y*

9.68%

*Annualized

Monthly Returns

The table below presents the monthly returns of UCBJY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-2.34%-2.18%-7.12%-11.77%-21.72%
20248.80%21.53%7.21%8.38%5.21%6.39%13.20%8.11%-0.57%6.40%2.13%1.53%130.84%
20234.28%5.42%3.78%4.06%-4.65%1.94%0.21%1.23%-8.65%-11.08%1.40%17.75%13.53%
2022-13.54%11.22%9.96%-4.07%-23.04%-4.22%-7.71%-9.40%-1.16%8.26%4.81%-0.70%-30.37%
20210.51%-3.69%-4.72%-2.70%2.99%11.29%3.44%5.75%-1.90%6.35%-9.30%5.46%12.28%
202014.14%-0.31%-5.56%5.56%11.03%15.67%11.15%-7.53%-4.43%-13.26%8.58%-3.52%30.04%
20196.49%-3.33%2.46%-6.18%-3.71%8.82%-5.32%-4.85%-2.95%11.34%0.33%-0.55%0.71%
201810.05%-4.55%-2.49%-4.97%3.91%-2.99%14.33%5.99%-2.95%-6.51%0.01%-3.04%4.63%
20177.18%3.71%8.89%1.77%-9.35%-2.75%5.65%-5.17%3.57%0.81%1.43%9.03%25.63%
2016-5.91%-12.56%3.01%-2.32%-1.80%3.25%4.81%4.78%-5.65%-12.58%-4.78%-0.22%-27.77%
20151.77%-1.50%-5.65%1.26%-0.97%0.52%8.51%-2.79%3.03%11.53%2.65%1.28%20.14%
2014-2.27%7.39%4.48%4.11%-2.60%6.08%8.49%5.70%-6.46%-11.15%-2.52%-2.75%6.55%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 78, UCBJY is among the top 22% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of UCBJY is 7878
Overall Rank
The Sharpe Ratio Rank of UCBJY is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of UCBJY is 7272
Sortino Ratio Rank
The Omega Ratio Rank of UCBJY is 7373
Omega Ratio Rank
The Calmar Ratio Rank of UCBJY is 8383
Calmar Ratio Rank
The Martin Ratio Rank of UCBJY is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for UCB SA ADR (UCBJY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for UCBJY, currently valued at 0.77, compared to the broader market-2.00-1.000.001.002.003.00
UCBJY: 0.77
^GSPC: 0.24
The chart of Sortino ratio for UCBJY, currently valued at 1.15, compared to the broader market-6.00-4.00-2.000.002.004.00
UCBJY: 1.15
^GSPC: 0.47
The chart of Omega ratio for UCBJY, currently valued at 1.17, compared to the broader market0.501.001.502.00
UCBJY: 1.17
^GSPC: 1.07
The chart of Calmar ratio for UCBJY, currently valued at 0.84, compared to the broader market0.001.002.003.004.00
UCBJY: 0.84
^GSPC: 0.24
The chart of Martin ratio for UCBJY, currently valued at 3.56, compared to the broader market-5.000.005.0010.0015.0020.00
UCBJY: 3.56
^GSPC: 1.08

The current UCB SA ADR Sharpe ratio is 0.77. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of UCB SA ADR with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.002.004.006.008.00NovemberDecember2025FebruaryMarchApril
0.77
0.24
UCBJY (UCB SA ADR)
Benchmark (^GSPC)

Dividends

Dividend History

UCB SA ADR provided a 0.93% dividend yield over the last twelve months, with an annual payout of $0.73 per share.


1.00%1.50%2.00%$0.00$0.20$0.40$0.60$0.80$1.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.73$0.73$1.03$0.70$0.77$0.67$0.68$0.73$0.62$0.62$0.57$0.72

Dividend yield

0.93%0.73%2.35%1.79%1.35%1.30%1.69%1.78%1.55%1.93%1.26%1.88%

Monthly Dividends

The table displays the monthly dividend distributions for UCB SA ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.73$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.73
2023$0.00$0.00$0.00$0.00$1.03$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.03
2022$0.00$0.00$0.00$0.70$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.70
2021$0.00$0.00$0.00$0.00$0.77$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.77
2020$0.00$0.00$0.00$0.00$0.67$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.67
2019$0.00$0.00$0.00$0.68$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.68
2018$0.00$0.00$0.00$0.73$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.73
2017$0.00$0.00$0.00$0.62$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.62
2016$0.00$0.00$0.00$0.00$0.62$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.62
2015$0.00$0.00$0.00$0.57$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.57
2014$0.72$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.72

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
UCBJY: 0.9%
UCB SA ADR has a dividend yield of 0.93%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%
UCBJY: 24.7%
UCB SA ADR has a payout ratio of 24.69%, which is quite average when compared to the overall market. This suggests that UCB SA ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-26.75%
-14.02%
UCBJY (UCB SA ADR)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the UCB SA ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the UCB SA ADR was 49.17%, occurring on Sep 22, 2022. Recovery took 384 trading sessions.

The current UCB SA ADR drawdown is 26.75%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-49.17%Jul 31, 2020541Sep 22, 2022384Apr 4, 2024925
-38.27%Aug 29, 2014560Dec 12, 2016316Aug 28, 2018876
-34.97%Mar 6, 202011Mar 23, 202049Jun 4, 202060
-28.58%Mar 5, 202527Apr 10, 2025
-25.17%Sep 13, 2018234Oct 2, 201965Feb 3, 2020299

Volatility

Volatility Chart

The current UCB SA ADR volatility is 11.22%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
11.22%
13.60%
UCBJY (UCB SA ADR)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of UCB SA ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how UCB SA ADR is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
UCBJY: 24.8
The chart displays the Price-to-Earnings (P/E) ratio for UCBJY, comparing it with other companies in the Biotechnology industry. Currently, UCBJY has a P/E ratio of 24.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
UCBJY: 2.3
The chart shows the Price/Earnings to Growth (PEG) ratio for UCBJY compared to other companies in the Biotechnology industry. UCBJY currently has a PEG ratio of 2.3. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
2.04.06.08.010.0
UCBJY: 5.0
This chart shows the Price-to-Sales (P/S) ratio for UCBJY relative to other companies in the Biotechnology industry. Currently, UCBJY has a P/S ratio of 5.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
UCBJY: 2.6
The chart illustrates the Price-to-Book (P/B) ratio for UCBJY in comparison with other companies in the Biotechnology industry. Currently, UCBJY has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for UCB SA ADR.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab